A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetry.

@article{Krintz2003ARO,
  title={A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetry.},
  author={Amanda L Krintz and William Hanson and Geoffrey S. Ibbott and David S. Followill},
  journal={International journal of radiation oncology, biology, physics},
  year={2003},
  volume={56 3},
  pages={889-98}
}
PURPOSE To recalculate the radiation doses delivered to structures of interest within the eye, i.e., the lens, tumor apex, 5-mm point, optic disk, and macula for patients treated with eye plaque radiotherapy on the Collaborative Ocular Melanoma Study (COMS) Medium Tumor Trial, using updated dosimetric data. METHODS AND MATERIALS Using the Plaque Simulator planning system, doses were recalculated for a sampling of COMS patients for each plaque size. Dosimetry parameters incorporated into the… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
5 Citations
27 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Verification of plaque simulator dose distribution using radiochromic film

  • AL Krintz, WF Hanson, GS Ibbott
  • Med Phys 2002;29:1220–1221
  • 2002
1 Excerpt

Collaborative Ocular Melanoma Study Group Design and Methods of a Clinical Trial for a Rare Condition . The Collaborative Ocular Melanoma Study , COMS Report No . 3

  • JE Freire, P DePotter, LW Brady
  • trol Clin Trials
  • 1993

Similar Papers

Loading similar papers…